Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EBIT Growth

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 293.46-104.66-19.84-13.0262.53

What is the latest EBIT Growth ratio of INDOCO REMEDIES ?

The latest EBIT Growth ratio of INDOCO REMEDIES is 293.46 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar2026293.46
Mar2025-104.66
Mar2024-19.84
Mar2023-13.02
Mar202262.53

How is EBIT Growth of INDOCO REMEDIES Trending?

Years EBIT Growth % Change
Mar2026 293.46
Positive
Mar2025 -104.66
Negative
Mar2024 -19.84
Negative
Mar2023 -13.02
Negative
Mar2022 62.53 -

Other Financial Ratios of INDOCO REMEDIES


Compare EBIT Growth ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,311.7 Cr 0.4% 11.2% -16.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,597.0 Cr 1% -3.3% 13.1% Stock Analytics
DIVIS LABORATORIES ₹255,195.0 Cr 2.6% 10.8% 57.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,712.0 Cr 2.7% 0.3% 39.6% Stock Analytics
CIPLA ₹113,423.0 Cr 2.4% -1.1% -12.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,195.0 Cr 2.5% 0.8% -8.5% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

0.4%

11.2%

-16.7%

SENSEX

-1%

-4.9%

-11%


You may also like the below Video Courses